Johnson & Johnson Innovation seeks to positively impact human health through innovation. We do this by helping entrepreneurs realize their dreams of creating healthcare solutions that improve peoples’ lives around the world. We work side-by-side with innovators throughout their journey, providing a robust exchange of ideas and resources to support their success. Our mission is to create the leading global innovation network to generate transformational healthcare solutions through value-creating partnerships. Our expertise spans multiple sectors: consumer, medical devices, pharmaceuticals, digital health and global public health.
Given the travel and safety regulations in place to combat the coronavirus COVID-19 pandemic, our Johnson & Johnson Innovation team is looking to present its external collaboration model and meet life sciences start-ups across Europe through virtual events and 1:1 sessions.
This event will target the German ecosystem. The event will include an open presentation on the Johnson & Johnson Innovation model on November 17, followed by one-to-one partnering meetings with selected companies on November 17 and 18.
November 17, 10:30-12:00 CET
The Johnson & Johnson Innovation Model: Innovation Through Collaboration
A briefing on our goals and mission, highlighting how we interact with the entrepreneurial community through incubation (JLABS), investment (JJDC), early stage partnerships and deals (Innovation Centers), and late stage deals (Business Development).
Virtual Partnering Meetings
Companies/researchers/organizations that are based in Germany and interested in talking to the team in 1:1 virtual meeting need to apply by 20 October EOD CETby submitting their non-confidential information. Successful applicants will be invited to virtual 1:1 meetings with the Johnson & Johnson Innovation team on 17-18 November.